Robotic movement therapy in cerebral palsy
E. Castelli
DOI: https://doi.org/10.1111/j.1469-8749.2011.03987.x
2011-06-01
Developmental Medicine & Child Neurology
Abstract:Neurodevelopmental disorders represent one of the more important clinical challenges for doctors and other professionals involved in rehabilitation medicine. It is well known that 60% of children with motor disabilities come under the umbrella term cerebral palsy (CP), the most prevalent severe neurodisability in childhood after intellectual impairment. CP is not a rare disease, with an overall prevalence of around 2 per 1000 live births. It is estimated that 650 000 families in Europe either have a child with CP or support an adult with CP. Therefore, treatment of these disorders represents an important part of total health spending. In recent years new technological devices have become available for rehabilitative management. For example, robotic exoskeletons worn during gait are being tested in adults with paraplegia from spinal cord injury. These devices are also of potential use in children and adults with CP. Robotic exoskeletons can radically change motor abilities in these patients, making them once again autonomous both in walking and using stairs. Today exoskeletons are available only for adults, while robot-mediated therapy (RMT) devices for the recovery of motor ability of the upper and lower limbs and in walking can be used by children. Muscle strengthening and exercise-based therapy are known to enhance motor recovery after brain injury, but the restoration of a function is largely mediated by neuroplasticity, the capability of the cerebral cortex to modify its functional organization as a result of experience. Changes in cortical maps are driven by specific aspects of behavioral demand (i.e. motivation, skill acquisition) and are not simply the result of repetitive use or strength training. The dosage (number of movements) and the intensity (movements per unit time) of the training are important and are critical factors for the activation of cortical plasticity. If this phenomenon generalizes to injured brains, then rehabilitation techniques should be optimal if they induce increasing levels of motor skill. RMT is able to produce and control different force fields (such as viscous, elastic, and gravitational) with high precision, and is customized to the particular needs of the patient, stimulating the tactile and proprioceptive systems. RMT provides force feedback for sensorimotor-type rehabilitative training, measuring speed, direction, and strength of residual activity, interactively evaluating patients’ movements, and assisting them in moving the impaired limb. It is an objective and reliable means of monitoring patient progress. RMT delivers training at much higher dosage and intensity. RMT allows the evaluation of quantitative indexes relative to the motor performance and monitoring of the results, according to the criteria of evidence-based rehabilitation. First results of clinical trials with these devices suggest that RMT may be an effective tool to ameliorate the debilitating effects of CP. RMT is a new rehabilitative opportunity; the video-game approach increases motivation in children and seems to be able to activate the neuroplasticity essential for recovery. Moreover, RMT delivers a highly reproducible motor learning experience, quantitatively monitors and adapts itself to the child’s progress, and ensures consistency in planning a therapy program. Integration of RMT with regular physiotherapy may further enhance its effectiveness. Perhaps, this vision is too optimistic. But time will tell whether and how much these technologies will move forward the limits of functional recovery and, as researchers and clinicians involved in childhood rehabilitation, which other strategies we should search for.